T
Tetsuya Mitsudomi
Researcher at Kindai University
Publications - 583
Citations - 51959
Tetsuya Mitsudomi is an academic researcher from Kindai University. The author has contributed to research in topics: Lung cancer & Epidermal growth factor receptor. The author has an hindex of 97, co-authored 541 publications receiving 46183 citations. Previous affiliations of Tetsuya Mitsudomi include University of Occupational and Environmental Health Japan & Gunma University.
Papers
More filters
Journal ArticleDOI
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
Ryota Shibaki,Hiroaki Akamatsu,Terufumi Kato,Kazumi Nishino,Morihito Okada,Tetsuya Mitsudomi,Kazushige Wakuda,Kenichi Yoshimura,Nobuyuki Yamamoto,Kazuhiko Nakagawa +9 more
TL;DR: In this article, an EGFR-mutated advanced non-small-cell lung cancer (NSCLC) was treated with TKI in the presence of EGFR mutation.
Journal ArticleDOI
A multicenter, open label, randomized phase III study of atezolizumab with platinum-pemetrexed and with or without bevacizumab for patients with advanced nonsquamous non-small cell lung cancer (WJOG11218L APPLE Study).
Yoshimasa Shiraishi,Haruko Daga,Satoshi Ikeda,Akito Hata,Hideaki Mizutani,Tomohiro Sakamoto,Haruhiro Saito,Osamu Hataji,Hiroshi Tanaka,Atsushi Horiike,Hideo Saka,Tsuneo Shimokawa,Masahide Mori,Katsuya Hirano,Koichi Azuma,Tetsuya Mitsudomi,Takashi Seto,Nobuyuki Yamamoto,Kazuhiko Nakagawa,Isamu Okamoto +19 more
TL;DR: First-line treatment of non–small cell lung cancer has undergone a paradigm shift to platinum combination therapy together with an immune-checkpoint inhibitor, and Bevacizuma is the first drug to be approved for this purpose.
Journal ArticleDOI
Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis.
Shuta Ohara,Kenji Tomizawa,Shigeki Shimizu,Kenichi Suda,Toshio Fujino,Akira Hamada,Takamasa Koga,Masaya Nishino,Yoshihisa Kobayashi,Katsuaki Sato,Masato Chiba,Masaki Shimoji,Toshiki Takemoto,Junichi Soh,Tetsuya Mitsudomi +14 more
TL;DR: The combination of Sjögren’s syndrome and MALT lymphoma is very rare, and this is the sixth resected case to the best of the authors' knowledge.
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia
Tetsuya Mitsudomi,Daniel Shao-Weng Tan,James Chih-Hsin Yang,Myung-Ju Ahn,Ullas Batra,Byoung Chul Cho,Gerardo H. Cornelio,Tony Kh. Lim,Tony Mok,Kumar Prabhash,Thanyanan Reungwetwattana,Shengxiang Ren,Navneet Singh,Shinichi Toyooka,Yi-Long Wu,Pan-Chyr Yang,Yasushi Yatabe +16 more
TL;DR: In this paper , the authors provided consensus recommendations for NSCLC biomarker testing from Asian lung cancer experts for clinicians working in Asia to improve patient care, and they divided the non-metastatic and metastatic forms of adenocarcinoma and squamous cell carcinoma.